HIV

Many patients with HIV develop neurocognitive disorders, which is incurable.

Up to half of people living with HIV experience HIV-associated neurocognitive disorders, a neurological manifestation of HIV-1 infection.

A combination therapy that attacks the viral reservoir may be crucial to controlling HIV replication without medication.

New research may overcome hurdles to eliminating viral reservoirs that prevent curing HIV.

The aging HIV population presents challenges to health care providers.

Officials with the FDA have approved ibalizumab-uiyk (Trogarzo, TaiMed Biologics), the first antiretroviral medication for adults with HIV who cannot be successfully treated with other therapies.

Mylan will reduce the wholesale acquisition costs of Smyfi Lo and Cimduo, which are both combination therapies for HIV.

HIV packages a key viral protein in exosomes to transport throughout the body.

New study findings suggest that more at-risk individuals should take pre-exposure prophylaxis to prevent HIV.

The authors of the study acknowledged that there is much more to be understood about the factors that affect adolescents and young adults at high risk for contracting or transmitting HIV.

Pre-exposure prophylaxis saves lives by reducing the risk of acquiring HIV, but the need for cost-saving is great.

Value-based contracts may also improve patient outcomes by increasing access to innovative medicines and supporting appropriate use.

The National Comprehensive Cancer Network seeks to address issues related to treating HIV-positive patients with cancer, such as the potential for drug interactions.

Top news of the week from Specialty Pharmacy Times.

Clarithromycin (Biaxin) may increase the risk of heart problems and death among patients with cardiovascular disease.

Clarithromycin (Biaxin) may increase the risk of heart problems and death among patients with cardiovascular disease.

Teens in the criminal justice system have a higher risk of contracting HIV.

Half of millennial-aged men and women said they have never been tested for HIV outside of blood donation.

Under the PEPFAR program, the antiretroviral (ARV) combination will be available in developing countries as a treatment for patients with HIV/AIDS.

Investigational small molecule drug may be able to treat herpes and HIV.

Health care professionals should provide resources that help patients with HIV practice self-care.

Crystalized dolutegravir may be able to reach viral reservoirs and cure HIV.

Many pharmacists are turning to credentialing as a way to distinguish themselves professionally.

As the job market for pharmacists becomes more competitive, many pharmacists are turning to credentialing as a way to distinguish themselves professionally.

Exposure to high levels of estrogen and progesterone may help curb proinflammatory cytokine and chemokine expression associated with HIV-1.